The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on high dose rate brachytherapy for carcinoma of the cervix.
following a CT scan or X-ray a treatment plan is produced for each patient treatment is then delivered directly to the tumour site by high dose rate brachytherapy equipment
X65.2 Delivery of a fraction of intracavitary radiotherapy
Y35.4 Introduction of radioactive substance into organ for brachytherapy NOC
Y89.1 High dose rate brachytherapy treatment
Z45.1 Cervix uteri
In addition an ICD-10 code from category C53.- Malignant neoplasm of cervix uteri is assigned.
The NHS Classifications Service of the Health and Social Care Information Centre is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. http://systems.hscic.gov.uk/data/clinicalcoding